5 results on '"P. James B. Dyck"'
Search Results
2. Chronic inflammatory demyelinating polyradiculoneuropathy and anesthesia: a case series
- Author
-
Juraj Sprung, Andrew R. Mortenson, James C. Watson, P. James B. Dyck, and Toby N. Weingarten
- Subjects
Adult ,Male ,medicine.medical_specialty ,Weakness ,Neurology ,medicine.medical_treatment ,Population ,Polyradiculoneuropathy ,Anesthesia, General ,03 medical and health sciences ,0302 clinical medicine ,030202 anesthesiology ,medicine ,Humans ,education ,Aged ,Retrospective Studies ,Aged, 80 and over ,Inflammation ,Mechanical ventilation ,education.field_of_study ,Muscle Weakness ,business.industry ,Muscle weakness ,Retrospective cohort study ,General Medicine ,Perioperative ,Middle Aged ,medicine.disease ,Surgery ,Polyradiculoneuropathy, Chronic Inflammatory Demyelinating ,Anesthesia ,Female ,Neurology (clinical) ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired autoimmune demyelinating polyneuropathy characterized by symmetrical diffuse weakness that also can rarely affect bulbar and respiratory muscles. The study objective was to describe perioperative outcomes of patients with CIDP who received general anesthesia. This retrospective observational study evaluated patients with active (diagnosed or treated within the previous year) CIDP who underwent general anesthesia at our institution between January 1, 2010, and December 31, 2015. Medical records were reviewed for perioperative outcomes with emphasis on respiratory complications or unexpected reactions to muscle relaxants. Seventeen patients with CIDP underwent general anesthesia, of whom 16 had muscle weakness. Succinylcholine was used in 5 cases (29.4%) and nondepolarizing muscle relaxants in 11 cases (64.7%). Two patients required postoperative mechanical ventilation; one was critically ill and the other had open heart surgery. One patient had aspiration on the second postoperative day and required endotracheal intubation and mechanical ventilation for 3 days. Three patients had worsening CIDP symptoms: 1 acutely after surgery; 1 several months later; and 1 who died in the hospital. The patient who died underwent lengthy abdominal exploration, had acute worsening of neurologic symptoms, and died after 46 days of malnutrition. Anesthetic concerns of patients with CIDP include frailty, bulbar dysfunction, and the effects of immunosuppressive therapy. Although our patients tolerated neuromuscular drugs, substantial theoretical concerns with these medications in patients with demyelinating neuropathies preclude safety in this population without further study.
- Published
- 2017
3. Hemi-body port-wine stains and progressive paresis due to territorial perineuriomas
- Author
-
P. James B. Dyck, Thom W. Rooke, Michelle L. Mauermann, Kimberly K. Amrami, Benjamin M. Howe, and Robert J. Spinner
- Subjects
Adult ,Pathology ,medicine.medical_specialty ,Port wine ,business.industry ,Port-Wine Stain ,Anatomy ,Magnetic Resonance Imaging ,Nerve Sheath Neoplasms ,Intraneural perineurioma ,Diagnosis, Differential ,Paresis ,Perineurioma ,Peripheral Nervous System Neoplasms ,Humans ,Medicine ,Female ,Radiology, Nuclear Medicine and imaging ,medicine.symptom ,business ,Brachial plexus ,Lumbosacral joint - Abstract
We present a case of a biopsy-proven intraneural perineurioma involving the left lumbosacral and brachial plexus with prominent hemi-body port wine stains in the associated dermatomes. The relationship between the two entities is not clear, but this case may provide a clue to understanding the etiological pathogenesis of intraneural perineurioma in the future.
- Published
- 2013
4. Treatment of Diabetic and Nondiabetic Lumbosacral Radiculoplexus Neuropathy
- Author
-
Pariwat Thaisetthawatkul and P. James B. Dyck
- Subjects
medicine.medical_specialty ,Plexus ,Neurology ,Diabetic neuropathy ,Nerve root ,business.industry ,medicine.disease ,Surgery ,Lumbosacral plexus ,Diabetes mellitus ,Anesthesia ,medicine ,Neurology (clinical) ,business ,Depression (differential diagnoses) ,Lumbosacral joint - Abstract
Lumbosacral radiculoplexus neuropathy (LRPN) is a multifocal, asymmetric, painful neuropathic disorder affecting multiple levels of lumbosacral plexus, nerve roots, and distal nerves that emerge from the plexus. The disorder was first described in diabetic patients (DLRPN) and was later found to occur in nondiabetic patients as well. There have been debates as to the pathogenesis of DLRPN and LRPN. Recent detailed and extensive pathologic studies, however, have shown that the main pathogenesis is inflammation and microvasculitis affecting various components in the peripheral nerves, resulting in ischemic injury to the nerves. Even though studies on the natural history of this disorder have shown that the majority of patients recover within a few years after the attack without any treatment (although recovery is incomplete in many cases), it is a common practice, based on the pathophysiology and case series, to administer immunotherapy. Preliminary data from a controlled clinical trial failed to show significant improvement in outcomes measured by neurologic deficits (as judged by the Neuropathy Impairment Score) but did show improvement in symptoms (pain and positive sensory symptoms). Choices of immunotherapy include corticosteroids, intravenous immunoglobulin, plasma exchange, or a combination. Pain management, physical therapy, and treatment of depression remain mainstays for managing this disorder.
- Published
- 2010
5. Vasculitic Neuropathies
- Author
-
Elie Naddaf and P. James B. Dyck
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Polyarteritis nodosa ,medicine.disease ,Cryoglobulinemia ,Dermatology ,Methylprednisolone ,Necrotizing Vasculitis ,Biopsy ,Rheumatoid vasculitis ,Medicine ,Neurology (clinical) ,business ,Vasculitis ,Microscopic polyangiitis ,medicine.drug - Abstract
From pathological standpoint, we divide vasculitic neuropathies in two categories: nerve large arteriole vasculitides and nerve microvasculitis. It is also important to determine whether a large arteriole vasculitis has an infectious etiology as it entails different treatment approach. Treatment of non-infectious large arteriole vasculitides consists initially of induction therapy with corticosteroids. Adding an immunosuppressant, mainly cyclophosphamide, is often needed. Treatment of infectious large arteriole vasculitides needs a multidisciplinary approach to target both the underlying infection and the vasculitis. Corticosteroids are the first-line therapy for classic non-systemic vasculitic neuropathy. Stable or improving patients without biopsy evidence of active vasculitis can be either observed or treated. Currently, adding an immunosuppressant is only indicated for patients who continue to progress on corticosteroids alone or patients with a rapidly progressive course. The treatment of the radiculoplexus neuropathies such as diabetic lumbosacral radiculoplexus neuropathy, lumbosacral radiculoplexus neuropathy (in non-diabetic patients), and diabetic cervical radiculoplexus neuropathy, as well as painless diabetic motor neuropathy, is not well established yet. We treat patients, if they present early on in the disease course or if they have severe disabling symptoms, with IV methylprednisolone 1 g once a week for 12 weeks.
- Published
- 2015
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.